Ocular involvement in idiopathic hypereosinophilic syndrome: a rare finding [Augenbeteiligung beim idiopathischen Hypereosinophilen Syndrom: ein seltener Befund]

Détails

ID Serval
serval:BIB_22AD31C848E8
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Ocular involvement in idiopathic hypereosinophilic syndrome: a rare finding [Augenbeteiligung beim idiopathischen Hypereosinophilen Syndrom: ein seltener Befund]
Périodique
Klinische Monatsblätter Für Augenheilkunde
Auteur⸱e⸱s
Balaskas K., Wyss P., Guex-Crosier Y.
ISSN
1439-3999 (Electronic)
ISSN-L
0023-2165
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
229
Numéro
4
Pages
437-438
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Résumé
Hypereosinophilic syndrome (HES) is a myeloproliferative disorder characterised by persistent eosinophilia associated with multiple organ damage. The three criteria required for the diagnosis of the disease are: a sustained absolute eosinophilic count in the serum greater than 1500/μl present for longer than 6 months, no aetiology for secondary eosinophilia present and identification of signs and symptoms of end-organ involvement [1][2]. Despite significant progress in our understanding of the pathogenesis of some forms of hypereosinophilic syndrome, the current state of knowledge is still insufficient to formulate a new comprehensive etiologic definition of HES [3]. Very few reports can be retrieved describing ocular involvement in HES. Retinal arteriolar occlusions were observed in the pre-equatorial region and documented by angiography in one report [4], while the principal defects noted in a second report were occlusions of major retinal vessels, choroidal infarct, and patchy or delayed choroidal filling [5]. We present a case of extensive bilateral choroidal infiltrates in a patient suffering from idiopathic hypereosinophilia, potentially attributable to her disease.
Mots-clé
Adrenal Cortex Hormones/therapeutic use, Chorioretinitis/diagnosis, Chorioretinitis/drug therapy, Female, Humans, Hypereosinophilic Syndrome/diagnosis, Hypereosinophilic Syndrome/drug therapy, Middle Aged, Rare Diseases, Treatment Outcome, Uveitis/diagnosis, Uveitis/drug therapy
Pubmed
Web of science
Création de la notice
01/05/2012 16:11
Dernière modification de la notice
20/08/2019 14:00
Données d'usage